Quadrature Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,064
| Closed | -$259K | – | 1056 |
|
|
2025
Q1 | $259K | Sell |
1,064
-736
| -41% | -$179K | 0.01% | 781 |
|
|
2024
Q4 | $592K | Sell |
1,800
-4,234
| -70% | -$1.39M | 0.01% | 545 |
|
|
2024
Q3 | $2.02M | Buy |
6,034
+739
| +14% | +$247K | 0.05% | 250 |
|
|
2024
Q2 | $1.45M | Sell |
5,295
-3,349
| -39% | -$914K | 0.02% | 374 |
|
|
2024
Q1 | $2.99M | Sell |
8,644
-15,176
| -64% | -$5.25M | 0.05% | 228 |
|
|
2023
Q4 | $7.7M | Buy |
23,820
+11,135
| +88% | +$3.6M | 0.14% | 104 |
|
|
2023
Q3 | $4.55M | Buy |
12,685
+12,143
| +2,240% | +$4.36M | 0.09% | 158 |
|
|
2023
Q2 | $205K | Buy |
542
+13
| +2% | +$4.93K | ﹤0.01% | 823 |
|
|
2023
Q1 | $254K | Sell |
529
-25,946
| -98% | -$12.4M | 0.01% | 711 |
|
|
2022
Q4 | $11.1M | Buy |
26,475
+16,654
| +170% | +$7.01M | 0.33% | 69 |
|
|
2022
Q3 | $4.1M | Buy |
9,821
+3,923
| +67% | +$1.64M | 0.13% | 161 |
|
|
2022
Q2 | $2.92M | Sell |
5,898
-9,893
| -63% | -$4.89M | 0.12% | 175 |
|
|
2022
Q1 | $8.89M | Buy |
15,791
+13,166
| +502% | +$7.41M | 0.36% | 69 |
|
|
2021
Q4 | $1.98M | Buy |
+2,625
| New | +$1.98M | 0.1% | 149 |
|
|
2021
Q3 | – | Sell |
-2,767
| Closed | -$1.78M | – | 707 |
|
|
2021
Q2 | $1.78M | Buy |
2,767
+700
| +34% | +$451K | 0.07% | 207 |
|
|
2021
Q1 | $1.18M | Buy |
+2,067
| New | +$1.18M | 0.06% | 280 |
|
|
2020
Q4 | – | Sell |
-1,600
| Closed | -$825K | – | 830 |
|
|
2020
Q3 | $825K | Buy |
+1,600
| New | +$825K | 0.05% | 390 |
|
|
2018
Q3 | – | Sell |
-1,528
| Closed | -$441K | – | 585 |
|
|
2018
Q2 | $441K | Buy |
+1,528
| New | +$441K | 0.04% | 337 |
|
|
2018
Q1 | – | Sell |
-3,124
| Closed | -$746K | – | 600 |
|
|
2017
Q4 | $746K | Buy |
+3,124
| New | +$746K | 0.07% | 266 |
|